User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

BHS 2013 recommendations for treatment of myelodysplastic syndromes

Primary tabs

Meers, S Breems, D Bries , G Delforge, M Graux, Carlos [UCL] Noens, L

(eng) The guidelines on the current state-of-the-art in the diagnosis and treatment of myelodysplastic syndromes of the Belgian Hematological Society working group on myelodysplastic syndromes were published in 2013.1 The key points of these guidelines are presented in two issues of the Belgian Journal of Hematology. In this paper we present the optimal treatment of patients with myelodysplastic syndromes within the current limitations of Belgian reimbursement modalities

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès restreint
Publication date 2015
Language Anglais
Journal information "Belgian Journal of Hematology" - Vol. 6, no. 2, p. 54-60 (2015)
Peer reviewed yes
Publisher Ariez International B.V. ((Netherlands) Wormer)
issn 2033-3749
Publication status Publié
Affiliations UCL - SSS/IREC/MONT - Pôle Mont Godinne
UCL - (MGD) Service d'hématologie
Keywords BHS ; Guidelines ; MDS ; Myelodysplastic syndromes ; Review
Links
Bibliographic reference Meers, S ; Breems, D ; Bries , G ; Delforge, M ; Graux, Carlos ; et. al. BHS 2013 recommendations for treatment of myelodysplastic syndromes. In: Belgian Journal of Hematology, Vol. 6, no. 2, p. 54-60 (2015)
Permanent URL http://hdl.handle.net/2078.1/161182